BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8175039)

  • 1. Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow.
    Benini C; Bandini G; Motta MR; Belardinelli AR; Calori E; Rizzi S; Martinelli G; Rosti G; Trabetti E; Pignatti P
    Haematologica; 1993; 78(6):414-5. PubMed ID: 8175039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow transplantation for a patient with ALL from her 75-year-old mother using cryopreserved bone marrow cells].
    Uike N; Suehiro Y; Takahira H; Shimada Y; Nagatoshi Y; Ikuno Y; Okamura J; Tasaka H; Miyamura T; Ishikura H
    Rinsho Ketsueki; 1994 Aug; 35(8):801-3. PubMed ID: 7933569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogeneic cryopreserved marrow transplantation in a patient with chronic myelogenous leukemia].
    Akatsuka Y; Takeshita T; Tsuzuki S; Suzuki R; Sugihara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1994 Mar; 35(3):304-8. PubMed ID: 8158854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical studies on patients who have undergone autologous or allogeneic bone marrow transplantation].
    Kasai M; Imai K; Seto K; Kobayashi N; Kawamura K; Higa T; Ariyama T; Meguro J; Kukita K; Yonekawa M
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):589-96. PubMed ID: 3065193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF stimulation of donor myelopoiesis prolongs survival of relapsed BCR-ABL-positive acute lymphoblastic leukemia after allogeneic marrow transplantation.
    Keil F; Kalhs P; Haas OA; Fritsch G; Lechner K; Mannhalter C; Greinix HT
    Bone Marrow Transplant; 1996 Sep; 18(3):655-7. PubMed ID: 8879636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation.
    Frey NV; Lazarus HM; Goldstein SC
    Bone Marrow Transplant; 2006 Sep; 38(6):399-405. PubMed ID: 16892075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
    Sasaki Y; Ito K
    Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
    Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
    Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
    van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R
    Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical reconstitution after bone marrow transplantation in twins who received fresh and cryopreserved grafts harvested at the same time from their older brother.
    Shinkoda Y; Ijichi O; Tanabe T; Ishikawa S; Kamitamari A; Nishikawa T; Ikarimoto N; Kawano Y
    Clin Transplant; 2004 Dec; 18(6):743-7. PubMed ID: 15516255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The distribution of donor hematopoietic stem cell and the ratio of lymphocytes from donor origin to recipient origin in recipient mice after allogeneic bone marrow transplantation].
    Shen SJ; Li XY; Wang LP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):393-6. PubMed ID: 16251017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
    Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
    Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT.
    Eckardt JR; Roodman GD; Boldt DH; Clark GM; Alvarez R; Page C; Gaskill H; LeMaistre CF
    Bone Marrow Transplant; 1993 Feb; 11(2):125-31. PubMed ID: 8435661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.